Orchid Pharma Share Price
954.65+20.00 (+2.14%)
+29.06% past 1 Year
Orchid Pharma (Orchid) established as an export-oriented unit (EOU) is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research manufacturing
Corporate filings & documents
Announcements
Appointment of cost auditor for FY 2026-27 and change in designation of director.
21 hours agoAppointment of cost auditor for FY 2026-27 and change in designation of director.
21 hours agoOutcome of Board meeting.
21 hours agoOutcome of Board meeting.
21 hours agoTranscript of Analysts/Investors earning call held with public at large on August 21 2026.
1 week agoTranscript of Analysts/Investors earning call held with public at large on August 21 2026.
1 week agoAudio Recording of the Analyst/Investor Earning Call for Q-1 ended on June 30 2026
1 week agoAudio Recording of the Analyst/Investor Earning Call for Q-1 ended on June 30 2026
1 week agoInvestors Presentation-Quarter 1 of F.Y.2026-27 ended on June 30 2026.
2 weeks agoInvestors Presentation-Quarter 1 of F.Y.2026-27 ended on June 30 2026.
2 weeks agoIntimation of schedule of Analysts/Investors Earning call for the Quarter-1 ended on June 30 2026.
2 weeks agoIntimation of schedule of Analysts/Investors Earning call for the Quarter-1 ended on June 30 2026.
2 weeks agoStatement of Deviation or variation for the quarter ended June 30 2026 on the use of proceeds of Funds raised through Qualified Institutional Placement.
2 weeks agoStatement of Deviation or variation for the quarter ended June 30 2026 on the use of proceeds of Funds raised through Qualified Institutional Placement.
2 weeks agoMonitoring Agency Report for Quarter-1 of F.Y. 2026-27 ended June 30 2026.
2 weeks agoMonitoring Agency Report for Quarter-1 of F.Y. 2026-27 ended June 30 2026.
2 weeks agoRevised Audited financial results for the Financial year ended March 31 2026 pursuant to Scheme of Merger
2 weeks agoRevised Audited financial results for the Financial year ended March 31 2026 pursuant to Scheme of Merger
2 weeks agoFinancial Results for Quarter-1 of F.Y. 2026-27 ended on June 30 2026.
2 weeks agoFinancial Results for Quarter-1 of F.Y. 2026-27 ended on June 30 2026.
2 weeks agoOutcome of Board meeting inter alia for considering and approving Unaudited Financial Results for Quarter-1 of F.Y. 2026-27 ended on June 30 2026.
2 weeks agoOutcome of Board meeting inter alia for considering and approving Unaudited Financial Results for Quarter-1 of F.Y. 2026-27 ended on June 30 2026.
2 weeks agoOrchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Limited reviewed financial result (standalone and consolidated) of the company for Quarter-1 ended on June 30 2026 and restated Audited (Standalone & Consolidated) Financial Results for the Quarter and Financial Year ended March 31 2026 on account of scheme of Amalgamation coming into effect
3 weeks agoOrchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Limited reviewed financial result (standalone and consolidated) of the company for Quarter-1 ended on June 30 2026 and restated Audited (Standalone & Consolidated) Financial Results for the Quarter and Financial Year ended March 31 2026 on account of scheme of Amalgamation coming into effect
3 weeks agoIntimation under regulation 30- Update on scheme of Amalgamation
1 month agoIntimation under regulation 30- Update on scheme of Amalgamation
1 month agoOutcome of Board Meeting held on August 01 2026
1 month agoOutcome of Board Meeting held on August 01 2026
1 month agoOrchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 inter alia to consider and approve Prior intimation of Board Meeting scheduled to be held on August 01 2026
1 month agoOrchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 inter alia to consider and approve Prior intimation of Board Meeting scheduled to be held on August 01 2026
1 month agoIntimation regarding Investor Roadshow
1 month agoIntimation regarding Investor Roadshow
1 month agoConfirmation certificate under Regulation 74(5) of Securities and Exchange board of India (Depositories and Participants) Regulations 2018.
1 month agoConfirmation certificate under Regulation 74(5) of Securities and Exchange board of India (Depositories and Participants) Regulations 2018.
1 month agoFixation of Record Date pursuant to scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited for alloting shares to Shareholders of Dhanuka Laboratories Limited
1 month agoFixation of Record Date pursuant to scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited for alloting shares to Shareholders of Dhanuka Laboratories Limited
1 month agoOutcome of Board Meeting: Amendment in the Capital Clause of Memorandum of Association of Company pursuant to the effectiveness of Scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited.
1 month agoOutcome of Board Meeting: Amendment in the Capital Clause of Memorandum of Association of Company pursuant to the effectiveness of Scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited.
1 month agoOutcome of the Board Meeting
1 month agoOutcome of the Board Meeting
1 month agoUpdate related to the Scheme of Amalgamation of Dhanuka Laboratories Limited ("Amalgamating Company") with Orchid Pharma Limited ("Amalgamated Company/Company") and their respective Shareholders and Creditors ("the Scheme") under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015("SEBI Listing Regulations") as amended.
1 month agoUpdate related to the Scheme of Amalgamation of Dhanuka Laboratories Limited ("Amalgamating Company") with Orchid Pharma Limited ("Amalgamated Company/Company") and their respective Shareholders and Creditors ("the Scheme") under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015("SEBI Listing Regulations") as amended.
1 month agoAnnouncement under Regulation 30 regarding the licensing and supply agreement with Pharmasyntez JSC Russia
1 month agoAnnouncement under Regulation 30 regarding the licensing and supply agreement with Pharmasyntez JSC Russia
1 month agoIntimation of trading window closure for the Quarter-I of Financial Year 2026-27 ending on June 30 2026
2 months agoIntimation of trading window closure for the Quarter-I of Financial Year 2026-27 ending on June 30 2026
2 months agoUpdate for receipt of copy of order related to scheme of Amalgamation of Dhanuka Laboratories limited and Orchid Pharma limited
2 months agoUpdate for receipt of copy of order related to scheme of Amalgamation of Dhanuka Laboratories limited and Orchid Pharma limited
2 months agoDisclosure regarding the order passed by Goods and Service Department.
2 months agoDisclosure regarding the order passed by Goods and Service Department.
2 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
May 2025
ConcallPresentation
Feb 2025
Nov 2024
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
May 2021
ConcallPresentation
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Plot Nos. 121-128, 128 A-133, 138-151, 159-164 Sidco Industrial Estate Alathur Chengalpattu Tamil Nadu PIN: 603110 Tel No: 044-44-2744 4471/72/73 Fax No: 044-28211002 Email: [email protected] / [email protected] Internet: www.orchidpharma.com
Registrars
Abhipra Complex, A-387, Azadpur, Dilkush Indl.Area, G T Karnal Road, New Delhi Delhi Abhipra Complex A-387 Azadpur Dilkush Indl.Area G T Karnal Road PIN: Tel No: 91-11-27127362 Fax No: 91-11-27215530 Email: NULL
Management
Ram Gopal Agarwal, Chairman
Manish Dhanuka, Managing Director
Mridul Dhanuka, Whole Time Director
Dharam Vir, Non Executive Independent Director
Manoj Kumar Goyal, Non Executive Independent Director
Shubha Singh, Non Executive Independent Woman Director
Tanu Singla, Non Executive Independent Woman Director
Arjun Dhanuka, Non Independent & Non Executive Director
Kapil Dayya, Company Secretary & Compliance Officer
Details
BSE 524372
NSE ORCHPHARMA
ISIN INE191A01027